CAS 28523-86-6
:Sévoflurane
- 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
- 347mmzEβγ
- Ether, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl
- Fluoromethyl 1,1,1,3,3,3-hexafluoro-2-propyl ether
- Fluoromethyl 1,1,1,3,3,3-hexafluoroisopropyl ether
- Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
- Mr 6S4
- R-E 347
- Sevocris
- Sevoflo
- Sevofluran
- Sevoflurane
- Sevofrane
- Sevohale
- Sevorane
- Ultane
- Fluoromethyl 1,1,1,3,3,3-hexafluoropropan-2-yl ether
- 1,1,1,3,3,3-Hexafluor-2-(fluormethoxy)propan
- oxyde de fluorométhyle et de 2,2,2-trifluoro-1-(trifluorométhyl)éthyle
- Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-
- Voir plus de synonymes
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
CAS :Formule :C4H3F7ODegré de pureté :>98.0%(GC)Couleur et forme :Colorless to Almost colorless clear liquidMasse moléculaire :200.06Sevoflurane
CAS :Ethers of monohydric alcohols, nesoiFormule :C4H3F7OCouleur et forme :Colorless Clear LiquidMasse moléculaire :200.05Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-
CAS :Formule :C4H3F7ODegré de pureté :98%Couleur et forme :LiquidMasse moléculaire :200.0548Sevoflurane
CAS :Formule :(CF3)2CHOCH2FDegré de pureté :≥ 99.5%Couleur et forme :Clear, colourless liquidMasse moléculaire :200.06Fluoromethyl 2H-hexafluoroprop-2-yl ether
CAS :Fluoromethyl 2H-hexafluoroprop-2-yl etherFormule :C4H3F7ODegré de pureté :≥95%Couleur et forme : clear. colourless liquidMasse moléculaire :200.05484g/molSevoflurane
CAS :Sevoflurane (Fluoromethyl), a noncompetitive inhibitor of 5-HT3 receptor, acts as a low-soluble inhalation anesthetics.Formule :C4H3F7ODegré de pureté :98%Couleur et forme :Less Oil Colorless OilMasse moléculaire :200.05Ref: TM-T22425
2mg39,00€5mg54,00€10mg75,00€25mg110,00€50mg158,00€100mg226,00€200mg339,00€1mL*10mM (DMSO)56,00€1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
CAS :Produit contrôléApplications 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane is an volatile anesthetic which inhibited activation of inflammatory neutrophil and granulocyte in human blood during simulated extracorporeal circulation.
References Schmid, E., et al.: Int. Immunopharmacol., 14, 202 (2012); Citerio, G., et al.: Euro. J. Anaesthesiol., 29, 371 (2012);Formule :C4H3F7OCouleur et forme :NeatMasse moléculaire :200.051,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
CAS :Formule :C4H3F7ODegré de pureté :98%(GC);RGCouleur et forme :Liquid, ClearMasse moléculaire :200.056Sevoflurane
CAS :Produit contrôléSevoflurane is an experimental drug that belongs to the group of intravenous anaesthetics. It has been shown to be effective in the prevention and treatment of myocardial infarcts. Sevoflurane inhibits polymerase chain reaction by binding to dinucleotide phosphate, which prevents DNA synthesis. It also inhibits oxidative injury in the heart, as well as genotoxic activity. Sevoflurane is a potent chemical inhibitor of the ryanodine receptor, which regulates calcium release from the sarcoplasmic reticulum. This inhibition results in reduced contractility and relaxation of vascular smooth muscle cells, leading to vasodilation and increased blood flow.
Formule :C4H3F7ODegré de pureté :Min. 95%Couleur et forme :Colorless PowderMasse moléculaire :200.05 g/mol












